Present criteria for prophylactic ICD implantation: Insights from the EU-CERT-ICD (Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter Defibrillators in EUrope) project

Autor: Zabel, M., Schlögl, S., Lubinski, A., Svendsen, J. H., Bauer, A., Arbelo, E., Brusich, S., Conen, D., Cygankiewicz, I., Dommasch, M., Flevari, P., Galuszka, J., Hansen, J., Hasenfuß, G., Hatala, R., Huikuri, H. V., Kenttä, T., Kuczejko, T., Haarmann, H., Harden, M., Iovev, S., Kääb, S., Kaliska, G., Katsimardos, A., Kasprzak, J. D., Qavoq, D., Lüthje, L., Malik, M., Novotny, T., Pavlovic, N., Perge, P., Röver, C., Schmidt, G., Shalganov, T., Sritharan, R., Svetlosak, M., Sallo, Z., Szavits-Nossan, J., Traykov, V., Vandenberk, B., Velchec, V., Vos, M. A., Willich, S. N., Friede, T., Willems, R., Merkely, B., Sticherling, C., investigators, the EU-CERT-ICD study

Publikováno v: Journal of Electrocardiology, 2019

BACKGROUND. The clinical effectiveness of primary prevention implantable cardioverter defibrillator (ICD) therapy is under debate. It is urgently needed to better identify patients who benefit from prophylactic ICD therapy. The EUropean Comparative E

Externí odkaz: http://arxiv.org/abs/1909.05571

High levels of lipoprotein (a) and premature acute coronary syndrome

Autor: Rallidis, Loukianos S., Pavlakis, George, Foscolou, Alexandra, Kotakos, Christos, Katsimardos, Andreas, Drosatos, Alexandros, Zolindaki, Maria, Panagiotakos, Demosthenes B.

Publikováno v: In Atherosclerosis February 2018 269:29-34

Clinical effectiveness of primary prevention implantable cardioverter-defibrillators: results of the EU-CERT-ICD controlled multicentre cohort study

Autor: Zabel, Markus, Willems, Rik, Lubinski, Andrzej, Bauer, Axel, Brugada, Josep, Conen, David, Flevari, Panagiota, Hasenfuß, Gerd, Svetlosak, Martin, Huikuri, Heikki V, Malik, Marek, Pavlović, Nikola, Schmidt, Georg, Sritharan, Rajevaa, Schlögl, Simon, Szavits-Nossan, Janko, Traykov, Vassil, Tuinenburg, Anton E, Willich, Stefan N, Harden, Markus, Friede, Tim, Svendsen, Jesper Hastrup, Sticherling, Christian, Merkely, Béla, Perge, Peter, Sallo, Zoltan, Szeplaki, Gabor, Szegedi, Nandor, Nagy, Klaudia Vivien, Lüthje, Lars, Sritharan, R, Haarmann, Helge, Bergau, Leonard, Seegers, Joachim, Munoz- Exposito, Pascal, Tichelbäcker, Tobias, Kirova, Aleksandra, Hnatkova, Katerina, Vos, Marc A, Reinhold, Thomas, Vandenberk, Bert, Klinika, Magdalena, Rotkvić, L, Flevari, Panayota, Katsimardos, Andreas, Katsaras, Dimitrios, Hatala, Robert, Kuczejko, Tomasz, Hansen, Jim, Manola, Šime, Vinter, Ozren, Benko, Ivica, Tuinenburg, Anton, Sprenkeler, David, Smoczynska, A, Vos, M A, Meyer-Zürn, Christine, Eick, Christian, Arbelo, Elena, Kaliska, Gabriela, Martinek, Jozef, Dommasch, Michael, Steger, Alexander, Kääb, Stefan, Sinner, Moritz F, Rizas, Konstantinos D, Hamm, Wolfgang, Traykov, V, Cygankiewicz, Iwona, Ptaszyński, Pawel, Kaczmarek, K, Poddebska, I, Iovev, Svetoslav, Novotný, Tomáš, Kozak, Milan, Huikuri, Heikki, Kenttä, Tuomas, Pelli, Ari, Kasprzak, Jaroslaw D, Qavoq, Dariusz, Brusich, Sandro, Avdovic, Ervin, Klasan, Marina, Galuszka, Jan, Taborsky, Milos, Velchev, Vasil, Dissmann, Rüdiger, Shalganov, T, Guzik, P, Krauze, T, Bimmel, Dieter, Lieberz, Christiane, Ludwigsburg, Klinikum, Stefanow, Stefan, Rüb, Norman, Wolpert, Christian, Meier, Lars S, Behrens, Steffen, Jurisic, Zrinka, Braunschweig, Frieder, Blaschke, Florian, Pieske, Burkert, Bakotic, Zoran, Anic, Ante, Weiden, Klinikum, Schwinger, Robert H G, Platonov, Pyotr, Grönefeld, Gerian, Klingenheben, Thomas, EU-CERT-ICD Study Investigators

Publikováno v: Zabel, M, Willems, R, Lubinski, A, Bauer, A, Brugada, J, Conen, D, Flevari, P, Hasenfuß, G, Svetlosak, M, Huikuri, H V, Malik, M, Pavlović, N, Schmidt, G, Sritharan, R, Schlögl, S, Szavits-Nossan, J, Traykov, V, Tuinenburg, A E, Willich, S N, Harden, M, Friede, T, Svendsen, J H, Sticherling, C, Merkely, B & EU-CERT-ICD Study Investigators 2020, ' Clinical effectiveness of primary prevention implantable cardioverter-defibrillators : results of the EU-CERT-ICD controlled multicentre cohort study ', European Heart Journal, vol. 41, no. 36, pp. 3437-3447 . https://doi.org/10.1093/eurheartj/ehaa226
European Heart Journal
Volume 41
Issue 36

Aims The EUropean Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter-Defibrillators (EU-CERT-ICD), a prospective investigator-initiated, controlled cohort study, was conducted in 44 centres and 15 Eu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::642c38d40a1d8c07d953f6ed45e8a5f1
https://doi.org/10.1093/eurheartj/ehaa226

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Ο προγνωστικός ρόλος της λιπονεκτίνης και της ρεζιστίνης σε ασθενείς με σταθερή στεφανιαία νόσο : Μελέτη παρακολούθησης τεσσάρων ετών

Autor: Andreas Katsimardos

Υπάρχουσα γνώση και αντικειμενικός σκοπός: Η αδιπονεκτίνη θεωρείται ότι έχει αντιαθηρογόνες ιδιότητες ενώ η ρεζιστίνη ότι προάγει την �

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c05039e9cc7a72b20533ebe3e70bdf60
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:2936319